|
1 Diet and Herbal-Derived Medicines |
|
|
1 | (20) |
|
|
1 | (2) |
|
1.2 Current Status of Food and Herbal-Based Medicine |
|
|
3 | (1) |
|
1.3 Medicinal Plants from Tradition to Evidence-Based Application |
|
|
4 | (7) |
|
|
5 | (1) |
|
|
5 | (1) |
|
|
6 | (1) |
|
1.3.4 Trigonella foenumgraecum |
|
|
6 | (1) |
|
|
6 | (1) |
|
|
7 | (1) |
|
|
7 | (1) |
|
|
7 | (1) |
|
|
7 | (1) |
|
|
8 | (1) |
|
|
8 | (1) |
|
1.3.12 Allium sativum, Garlic, and Onion (Allium cepa L.) |
|
|
8 | (1) |
|
|
9 | (1) |
|
1.3.14 Melissa officinalis |
|
|
9 | (1) |
|
|
9 | (1) |
|
1.3.16 Chamomilla recutita |
|
|
10 | (1) |
|
1.3.17 Zingiber officinale |
|
|
10 | (1) |
|
1.3.18 Rosmarinus officinalis |
|
|
10 | (1) |
|
1.4 Administering Herbal-Based Treatment |
|
|
11 | (1) |
|
1.5 Herbal Active Compounds |
|
|
11 | (2) |
|
1.6 Synergistic Actions of Foods and Phytomedicines |
|
|
13 | (1) |
|
1.7 Therapeutic Properties of Herbal-Based Active Compounds |
|
|
14 | (1) |
|
1.8 Examples of Herbal Compounds and Pharmacological Properties |
|
|
15 | (1) |
|
|
16 | (5) |
|
|
17 | (4) |
|
2 Introduction to Anthocyanins |
|
|
21 | (14) |
|
|
21 | (2) |
|
|
23 | (5) |
|
2.2.1 Glycone Moiety and Acylating Acids |
|
|
24 | (4) |
|
|
28 | (1) |
|
|
28 | (7) |
|
|
31 | (4) |
|
3 Occurrence of Anthocyanins in Plants |
|
|
35 | (12) |
|
|
35 | (2) |
|
3.2 Concentration of Anthocyanins in Fruits, Vegetable and Nuts |
|
|
37 | (3) |
|
3.2.1 Variation in Anthocyanins Content |
|
|
38 | (2) |
|
3.3 Typical New Anthocyanins Found in the Past Years |
|
|
40 | (2) |
|
|
42 | (5) |
|
|
42 | (5) |
|
4 Anthocyanins as Natural Colors |
|
|
47 | (10) |
|
|
47 | (4) |
|
4.2 Use of Anthocyanin-Based Colorants |
|
|
51 | (1) |
|
4.3 Acylated Anthocyanins as Colorants for the Food Industry |
|
|
52 | (2) |
|
|
54 | (3) |
|
|
54 | (3) |
|
5 Anthocyanins Absorption and Metabolism |
|
|
57 | (14) |
|
|
57 | (1) |
|
|
58 | (1) |
|
5.3 Anthocyanins Absorption |
|
|
59 | (5) |
|
|
60 | (1) |
|
5.3.2 Absorption in the Small Intestine |
|
|
60 | (2) |
|
|
62 | (2) |
|
5.4 Carbohydrates Moieties Deconjugation |
|
|
64 | (1) |
|
5.5 The Influence of Colonic Microflora |
|
|
64 | (1) |
|
5.6 Metabolism in Intestinal Mucosa and Tissues |
|
|
65 | (1) |
|
|
65 | (1) |
|
|
66 | (1) |
|
|
67 | (4) |
|
|
67 | (4) |
|
6 Biosynthesis and Stability of Anthocyanins |
|
|
71 | (16) |
|
|
71 | (2) |
|
6.2 Stability of Anthocyanins |
|
|
73 | (1) |
|
6.3 Relationships Between Structure and Stability |
|
|
74 | (1) |
|
6.4 Factor Affecting Stability of Anthocyanins |
|
|
75 | (5) |
|
|
75 | (1) |
|
6.4.2 Co-pigmentation Effect |
|
|
75 | (2) |
|
|
77 | (1) |
|
|
78 | (1) |
|
6.4.5 Concentration Effects |
|
|
78 | (1) |
|
|
78 | (1) |
|
|
78 | (1) |
|
|
79 | (1) |
|
|
79 | (1) |
|
|
79 | (1) |
|
|
80 | (1) |
|
6.5 Stability of Anthocyanins in Food Products |
|
|
80 | (1) |
|
6.6 Anthocyanins Degradation in Plants |
|
|
80 | (1) |
|
6.7 Drawback and Derivatives of Anthocyanins |
|
|
81 | (1) |
|
6.8 Anthocyanins Stabilization Mechanisms |
|
|
81 | (2) |
|
|
83 | (4) |
|
|
83 | (4) |
|
7 The Role of Anthocyanins in Health as Antioxidant, in Bone Health and as Heart Protecting Agents |
|
|
87 | (22) |
|
|
87 | (1) |
|
7.2 Presumed Health-Promoting Effects of Anthocyanins |
|
|
88 | (3) |
|
7.3 Toxicity of Anthocyanins |
|
|
91 | (1) |
|
7.4 Reproductive and Developmental Toxicity |
|
|
92 | (1) |
|
7.5 Anthocyanins Biological and Pharmacological Activities |
|
|
92 | (1) |
|
|
93 | (2) |
|
7.7 Protection Against Cardiovascular Diseases |
|
|
95 | (3) |
|
7.8 Anthocyanins and Bone Health |
|
|
98 | (2) |
|
|
100 | (9) |
|
|
101 | (8) |
|
8 The Role of Anthocyanins in Obesity and Diabetes |
|
|
109 | (16) |
|
|
109 | (1) |
|
8.2 Anthocyanins and Obesity |
|
|
110 | (1) |
|
8.3 Anthocyanins and Diabetes |
|
|
111 | (6) |
|
|
112 | (1) |
|
|
113 | (1) |
|
|
114 | (1) |
|
|
115 | (1) |
|
8.3.5 α-Glucosidase Inhibitory Action |
|
|
115 | (1) |
|
8.3.6 Obesity and Diabetes |
|
|
116 | (1) |
|
8.4 Improvement of Eye Vision |
|
|
117 | (2) |
|
|
119 | (6) |
|
|
119 | (6) |
|
9 Anthocyanins Effects on Carcinogenesis, Immune System and the Central Nervous System |
|
|
125 | |
|
|
125 | (1) |
|
9.2 Anti-Inflammatory Activity |
|
|
125 | (1) |
|
9.3 Anthocyanins and Cancer |
|
|
126 | (5) |
|
9.4 Anthocyanins, Alzheimer Diseases and Brain Function |
|
|
131 | (1) |
|
9.5 Miscellaneous Activities |
|
|
131 | (2) |
|
9.6 Pharmaceutical Products |
|
|
133 | (1) |
|
|
133 | |
|
|
134 | |